HPRA investigates first Irish blood clot case linked to AstraZeneca vaccine
DUBLIN: The Health Products Regulatory Authority (HPRA) is investigating the first reported case of a blood clot in Ireland following the administration of the AstraZeneca COVID-19 vaccine. The blood clot was reported in a pregnant woman who had been vaccinated with AstraZeneca. HPRA has confirmed that a detailed investigation has been launched into the matter.
A 40 – year – old pregnant woman in Dublin has been diagnosed with the blood clot in her brain. She is being treated in the Mater Hospital. The available information is that the treatment was successful and she will be discharged in the coming days.
The HPRA is investigating at a blood clot related to the vaccine, which describes CVST, a rare clot in the brain. “We are following up on this report to obtain additional details and to evaluate if it is consistent with the profile of rare blood clotting events that were the focus of the recently concluded EMA safety review,” the HPRA said.
“This report will be notified to the EU’s safety database and will be considered in the context of continuous monitoring coordinated by the EMA,” the regulator added. HPRA said that it could not comment further on the case due to confidentiality reasons.
Earlier, the European Medicines Agency (EMA) stated that there is a possible link between the vaccine and rare cases of blood clots.
The National Immunisation Advisory Committee is meeting to decide whether new vaccine guidelines should be implemented in the country.
Kindly click the link below to join WhatsApp group chat to get important news and breaking news from Irish Samachar
Comments are closed.